# Correction: Construction of antifungal dual-target (SE, CYP51) pharmacophore models and the discovery of novel antifungal inhibitors

## TL;DR

This paper corrects a previous study on developing antifungal drug models targeting two enzymes and identifying new inhibitors.

## Contribution

The correction provides updated information or clarifications regarding the pharmacophore models and antifungal inhibitors described in the original paper.

## Key findings

- The original study aimed to construct dual-target pharmacophore models for antifungal agents.
- The correction addresses potential errors or omissions in the initial findings and methodology.
- New insights or revised conclusions may improve the development of antifungal drugs.

## Abstract

Correction for ‘Construction of antifungal dual-target (SE, CYP51) pharmacophore models and the discovery of novel antifungal inhibitors’ by Yue Dong et al., RSC Adv., 2019, 9, 26302–26314, https://doi.org/10.1039/c9ra03713f.